AdvertisementPfizer's Rheumatoid Arthritis Pill Shows Promise In Big StudiesNovember 08, 2010Scott HensleyfacebookEmailPfizer's experimental rheumatoid arthritis drug targets the JAK3 protein, which looks like this. (Wikimedia Commons)
